
Keywords: AE; adverse event; AI; aromatase inhibitor; CBT; cognitive behavior therapy; CHC; combined hormonal contraceptive; CNS; central nervous system; DHEA; dehydroepiandrosterone; DSDS; Decreased Sexual Desire Screener; HCP; health care professional; HSDD; hypo